HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Knockdown of RREB1 inhibits cell proliferation via enhanced p16 expression in gastric cancer.

Abstract
Gastric cancer (GC) is the most common gastrointestinal malignancy worldwide. However, the molecular mechanisms of the progression of GC are not fully understood. Ras-responsive element binding protein 1 (RREB1) is an oncogene in many types of cancer that is involved in various biological processes, such as DNA damage repair, cell growth and proliferation, cell differentiation, fat development, and fasting glucose balance. In this study, we demonstrate the role of RREB1 in gastric cancer. First, by immunohistochemistry staining (IHC) and bioinformatics analysis, we demonstrated the expression of RREB1 in gastric cancer and paired normal gastric tissues. Then, we established RREB1 overexpression and knockdown cell lines via lentiviral transfection and detected cell proliferation by using MTT, colony-forming, cell cycle and apoptosis assays in vitro. We demonstrated the effect of RREB1 on cell proliferation in vivo by using a subcutaneous xenograft tumor model in nude mice. Finally, by using Western blotting and IHC, we demonstrated the possible mechanism by which RREB1 affects cell proliferation. The IHC and bioinformatics analyses demonstrated that RREB1 was highly expressed in gastric cancer and showed that RREB1-expressing patients had a larger tumor size and more lymphovascular invasion than RREB1-negative patients. Knockdown of RREB1 inhibited cell proliferation in vivo and in vitro. Knockdown of RREB1 enhanced p16 expression in vivo and in vitro, and p16 expression was negatively related to RREB1 in gastric cancer tissue. RREB1 was highly expressed in gastric cancer, and knockdown of RREB1 inhibited cell proliferation via enhanced p16 expression.
AuthorsQi Gao, Yunhua Wu, Chaoxiang Lu, Wang Kai, Weike Xie, Qi Wang, Lei Wang, Shiqi Liu, Yongkang Pan
JournalCell cycle (Georgetown, Tex.) (Cell Cycle) Vol. 20 Issue 23 Pg. 2465-2475 (12 2021) ISSN: 1551-4005 [Electronic] United States
PMID34666611 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA-Binding Proteins
  • RREB1 protein, human
  • Transcription Factors
Topics
  • Animals
  • Apoptosis (genetics)
  • Cell Line, Tumor
  • Cell Proliferation (genetics)
  • Cyclin-Dependent Kinase Inhibitor p16 (biosynthesis, genetics)
  • DNA-Binding Proteins (genetics, metabolism)
  • Gene Knockdown Techniques
  • Heterografts
  • Humans
  • Mice
  • Mice, Nude
  • Oncogenes
  • Stomach Neoplasms (genetics, metabolism, pathology)
  • Transcription Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: